Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid
- PMID: 27062568
- PMCID: PMC4992418
- DOI: 10.3233/CBM-160609
Optimizing preservation of extracellular vesicular miRNAs derived from clinical cerebrospinal fluid
Abstract
Background: Tumor specific genetic material can be detected in extracellular vesicles (EVs) isolated from blood, cerebrospinal fluid (CSF), and other biofluids of glioblastoma patients. As such, EVs have emerged as a promising platform for biomarker discovery. However, the optimal procedure to transport clinical EV samples remains poorly characterized.
Methods: We examined the stability of EVs isolated from CSF of glioblastoma patients that were stored under different conditions. EV recovery was determined by Nanoparticle tracking analysis, and qRT-PCR was performed to determine the levels of miRNAs.
Results: CSF EVs that were lyophilized and stored at room temperature (RT) for seven days exhibited a 37-43% reduction in EV number. This reduction was further associated with decreased abundance of representative miRNAs. In contrast, the EV number and morphology remained largely unchanged if CSF were stored at RT. Total RNA and representative miRNA levels were well-preserved under this condition for up to seven days. A single cycle of freezing and thawing did not significantly alter EV number, morphology, RNA content, or miRNA levels. However, incremental decreases in these parameters were observed after two cycles of freezing and thawing.
Conclusions: These results suggest that EVs in CSF are stable at RT for at least seven days. Repeated cycles of freezing/thawing should be avoided to minimize experimental artifacts.
Keywords: CSF; EV; exosome; freeze thaw; lyophilization; stability.
Conflict of interest statement
COMPLIANCE WITH ETHICAL RESEARCH STANDARDS The authors declare no conflicts of interest. All research on human subjects presented in this paper was conducted in accordance with the ethical research standards prescribed by the responsible national/institutional committee on human experimentation and with the WMA Declaration of Helsinki as of its 7th revision in 2013. Informed consent was obtained from all human subjects participating in the study.
Figures



References
-
- Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10:472–484. - PubMed
-
- Rabinowits G, Gercel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009;10:42–46. - PubMed
-
- Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110:13–21. - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous